Endobronchial Metastases from Extrathoracic Malignancies

By Akoglu Sebahat   Uçan Eyüp   Çelik Gülperi   Şener Gülper   Sevinç Can   Kılınç Oğuz   İtil Oya  

Clinical and Experimental Metastasis, Vol. 22, Iss. 7, 2005-11 ,pp. : 587-591

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?

By Vassiliou Vassilios   Kalogeropoulou Christine   Petsas Theodoros   Leotsinidis Michael   Kardamakis Dimitrios  

Clinical and Experimental Metastasis, Vol. 24, Iss. 1, 2007-03 ,pp. : 49-56

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 713-720

John Wiley & Sons Inc

Access to resources Recommend Favorite

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

By Christodoulou Christos   Bafaloukos Dimitrios   Linardou Helen   Aravantinos Gerassimos   Bamias Aristotelis   Carina Maria   Klouvas George   Skarlos Dimosthenis  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 61-65

Springer Publishing Company

Access to resources Recommend Favorite

Disease Progression Increases the Risk of Skeletal-Related Events in Patients With Bone Metastases From Castration-Resistant Prostate Cancer, Lung Cancer, or Other Solid Tumors

By Simon Tchekmedyian N.   Chen Yin-Miao   Saad Fred  

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 849-855

Informa Healthcare

Access to resources Recommend Favorite